This detailed book serves as a laboratory manual containing vital protocols and in-depth discussion involving commonly used experimental approaches for the characterization of several aspects of lung tumor biology. Beginning with an extensive section on biomarker detection, the volume continues with chapters on the genetic and molecular characterization of lung cancer biological samples as well as protocols for the generation of research tools and pre-clinical lung cancer models. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and practical, Lung Cancer: Methods and Protocols provides a global perspective of research efforts related to lung cancer, while allowing researchers to experimentally probe the different aspects of lung cancer research, including the experimentally relevant tests used in the establishment of lung cancer diagnosis and prognosis, in their laboratories.

This book comprehensively describes alkaptonuria and ochronosis. Beginning with the history, genetics, pathophysiology and diagnostics of the disease, the authors subsequently present a detailed characterization of its clinical manifestation in the spine, peripheral joints, eyes, ears, visceral organs and respiratory tract, its pathological anatomy and histology, as well as differential diagnosis. This is complemented by the latest data on therapy and experimental models of alkaptonuria, and supported by several case reports. Numerous pictures and radiological images document the clinical symptoms, giving the reader a solid understanding of the disease. On the basis of the editor's and authors' own extensive observations, the book offers an analysis of protein metabolism and aromatic amino acids in the context of alkaptonuria. Written by international experts in the field, the book offers a valuable reference guide for healthcare professionals working in rheumatology, dermatology, pulmonology, otolaryngology and histopathology.

Chronic obstructive pulmonary disease (COPD) is a multi-component condition that results in increasingly limited airflow, usually associated with an abnormal inflammatory response of the lung. It constitutes a major public health burden worldwide, while only very few effective therapies are available. This book provides a comprehensive overview of the development of Onbrez Breezhaler, a newly approved once-daily inhaled ?2 agonist for the treatment of COPD. It reviews the current pharmacotherapy for COPD and discusses topics such as the chemical design and the pre-clinical pharmacology of the molecule, the early clinical development, the INHANCE study (which provides a successful example of the use of an adaptive design in the confirmatory setting) and the Phase III clinical efficacy study, as well as the history and performance of the Breezhaler device. Finally, a list of emerging targets is included that could well offer future treatment options for COPD.

This new book provides an accessible review of the field of lung biology and disease aimed at the graduate or medical student and biomedical researcher. The book starts by considering the anatomy and ultrastructure of the lung and the tracheal and bronchial system, the control of respiration as well as the fundamentals of pulmonary physiology, gas exchange and circulation. This is followed by discussion of the regulation of acid-base balance, high altitude physiology and pathophysiology as well as exercise and the pulmonary system. Chapters follow on the immunology of the lung, lung injury, asthma and emphysema, granulomatous lung disease, inhalation of toxic substances as well as diseases of the small airways. The final chapter considers current research into lung transplantation.

First major evidence-based text in adult respiratory medicineComprehensive, authoritative summary of the best treatments for the major respiratory diseasesCompiled by specialists from the Cochrane Airways Management GroupEasy-to-use format, with key clinical implications summarised in each chapterKept up-to-date online

Compiled by specialists from the Cochrane Collaboration Airways Management Group, "Evidence-based Respiratory Medicine" is the first major evidence-based text in adult respiratory medicine.

Providing a comprehensive summary of the best treatments for the most important respiratory diseases, some of the world's leading physicians review the evidence for a broad range of treatments using evidence-based principles. Essential information is presented in an easy-to-understand format, with the most important clinical implications summarised in each chapter.

"Evidence-based Respiratory Medicine" tackles the big clinical questions in diagnosis and treatment, presenting treatment options which take into account the individual patient's needs.

Evidence-Based Series: "Evidence-based Respiratory Medicine, " part of the acclaimed series BMJ Evidence-based medicine textbooks that have revolutionised clinical medicine literature, comes with a fully searchable CD-ROM of the whole text.

Note: CD-ROM/DVD and other supplementary materials are not included as part of eBook file.

Chronic obstructive pulmonary disease (COPD) ranges amongst the commonest diseases in the world. The relentless progression of the disease causes a pressing need for a better understanding of and therapies for COPD. This volume provides state-of-the-art information on the pathophysiology of COPD including an outlook on new therapies. It is of interest to researchers and clinicians in academia as well as in the pharmaceutical industry.

This book discusses a wide range of investigations and practice-oriented advances in pulmonary medicine and critical care. Pulmonary diseases are a major cause of hospitalization and mortality, affecting millions of people worldwide. Addressing a range of topics, including chronic obstructive pulmonary disease, sleep apnea, and lung cancer, the book offers insights into the disease mechanisms and risk factors, along with practical aspects concerning the maintenance of quality of life, adherence to therapy, and palliative treatment and care. Further, it explores diagnostic and treatment approaches to respiratory dysfunction and respiratory failure, highlighting the beneficial effects of good sleep quality in chronic pulmonary conditions and lung transplant patients. The book also presents novel experimental research on the cellular voltage-gated sodium channels in the mechanism of pathological cough, which is particularly relevant for future targeted antitussive therapy. Lastly, it addresses the epidemiological aspects of pulmonary infections. As such, this book is a valuable resource for medical scholars, clinicians, family physicians, and other professionals seeking to improve the management of respiratory diseases.

A host of neurotransmitters and neuroactive substances underlies respiratory regulation in health and disease. The centerpiece of investigations regarding adaptation to hypoxia and sensorial perception has been the dopaminergic system. It is now clear that a complex interaction among various neuroactive substances, rather than a single one, forms the basis of respiratory changes. The research on neurotransmitter interactions provides the knowledge of how the brain functions and a new level of understanding of mind-to-body connection, which opens up avenues for novel therapeutic interventions.

In a simplified form, epigenetics refers to heritable changes in phenotype that are not due to changes in the underlying DNA sequence. In this book, epigenetic mechanisms of regulation and dysregulation in health and disease are explored in great depth. Detailed chapters on epigenetic processes including DNA methylation and chromatin post-translational modifications including potential interventions with DNA methyltransferase inhibitors and histone deacetylase inhibitors are explored in initial chapters. These provide a detailed overview and important background to the entire field. The book is then focussed on epigenetic mechanisms involved in various diseases including anti-inflammatory and autoimmune conditions. Important accounts relating to the effects of epigenetics in metabolic syndrome, cardiovascular disease and asthma are the focus of subsequent chapters. The role of epigenetic dysregulation in malignancy is a current topic of interest and represents an intense field of research. A large component of this book is dedicated to the analysis of aberrant epigenetic processes in carcinogenesis and cancer progression. Further, chapters are focused on emerging cancer prevention using nutritional components and anti-cancer therapies particularly with histone deacetylase inhibitors, which have already been approved for the treatment of cutaneous T-cell lymphoma. The emerging role of nanoparticle preparations, especially in the context of delivering potential epigenetic therapies to target cells in various diseases, is also explored in this book. Overall, this book encompasses a wide range of topics related to epigenetic mechanisms in health and disease and would appeal to anyone with an interest in epigenetics, chromatin biology and emerging epigenetic interventions and therapies.

This book presents original articles that report on new approaches and developments involving pulmonary disorders. Pulmonary health attracts public concern as lungs are the first line of defense of the organism against various contagions and are directly influenced by all too often unhealthy constituents of ambient air, which make them vulnerable to diseases. The articles deal with the pathogenic background and most relevant practical aspects of the widespread pulmonary disorders. Topics include the mechanisms and treatment options of sleep apnea syndrome, occupational exposure to carbon dioxide, and the research on prognostic factors in lung cancer. Another theme tackles quality of life in chronic pathologies and the psychosocial factors, often underestimated, having influence on lung function already in adolescence, and thus liable to shape adult pulmonary morbidity. Reports on the course of recent influenza outbreaks and a rather dismal state of anti-influenza measures top off the content. The volume is addressed to clinicians and researchers, pulmonary doctors, and other professionals engaged in patient care and therapy.

Both communicable and noncommunicable diseases of the respiratory system are an increasing healthcare problem despite medical advances. This book aims at unraveling the mechanisms and improving the treatment of pulmonary pathologies, ranging from such common conditions like influenza and related viral infections, functional lung dysfunction, to lung lesions and others. Chapters present late-breaking findings in the diagnostics, pharmacotherapy, and clinical evidence-based decision-making to provide results that can be used to improve healthcare and quality of life. Extending new knowledge and exploring recent medical advances, the book will hopefully help enrich research and clinical experience regarding important respiratory issues. The book is intended for general practitioners and all professionals engaged in the pulmonary field, from basic scientists to clinical investigators.

This is the second volume of the comprehensive, two-volume work on oxidative stress in lung diseases. Adopting a multidisciplinary approach, it demonstrates the cellular and molecular mechanisms associated with ROS (reactive oxygen species)-induced initiation and progression of a variety of lung diseases, such as COPD, emphysema, asthma, cystic fibrosis, occupational pulmonary diseases and pulmonary hypertension and discusses points for therapeutic intervention. The book also covers translational research and the latest research on prevention and therapeutics. Each chapter includes in-depth insights into the mechanisms associated with lung diseases and into identifying targets for drug development. Bridging the gap between fundamental and translational research, and examining applications in the biomedical and pharmaceutical industry, it is a thought- provoking read for basic and applied scientists engaged in biomedical research.

Pulmonary disorders significantly contribute to the current level of disease burden. Effective disease management is essential for improving clinical outcomes and quality of life. This book highlights the issues involved with diagnosing and managing various pulmonary conditions such as chronic obstructive pulmonary disorders, respiratory tract infections, including those developing as a sequel of antibiotic treatment, and others. Investigations on novel diagnostic procedures and potential biomarkers of diseases are discussed, along with disease presentations and management. Preventive measures related to lifestyle and air quality, with the implications on patients care, are tackled as well. Progress in clinical savvy is inseparably linked with getting an insight into the pathogenesis of a condition. This book presents views and information on the research developments in the rapidly changing field of pneumology. Target readership: clinicians and researchers, family practitioners, and trainees.

Clinical investigation plays an essential role in the differential diagnosis, biomarker development, and therapy and cure of diseases. The book presents a bench-to-bed approach, with broad empirical coverage by experienced practitioners. The articles include topics like cytokine receptors in lung cancer, conduciveness of oxidative stress to carcinogenesis, safety and effectiveness of surgical correction of deformed chest, diagnostic and treatment regimens in inflammation-ridden obstructive lung conditions, alterations in growth hormone secretion leading to disorders of growth and metabolism, microbiota transplantation in pediatric patients, and the promising markers of renal epithelial injury. Yet another issue concerns the restructuring of chronic pain management by establishing the community-based specialized pain clinics. The book aims to disseminate and deliberate on the latest interdisciplinary medical knowledge to enhance clinical outcomes. Being a blend of clinical investigation and practice the book is addressed to physicians, scientists, and allied health care professionals.

This book describes various aspects of current scientific interest in clinical developments and management of pulmonary pathologies. Non-communicable and communicable disorders are tackled. Chronic disorders of an inflammatory background, such as COPD and asthma, often overlapping, diagnostically and therapeutically misguided and always difficult to manage, are in focus due to an increasing prevalence across the age range. The authors dwell on the disease management, exacerbations, care and therapy, taking into account all too often overlooked psychosomatic determinants. Novel markers of pulmonary sarcoidosis, also an inflammatory disease, albeit of unknown etiology, are described. The outstanding lung images of cystic fibrosis are presented in another chapter. Finally, there are reports on the extent of the influenza scourge in Poland during the past 2016/2017 epidemic season. The book is addressed to clinicians, family physicians, medical scholars, and all professionals engaged in the preservation of respiratory health.

How does it feel to confront a pandemic from the inside, one patient at a time? To bridge the gulf between a perilously unwell patient in quarantine and their distraught family outside? To be uncertain whether the protective equipment you wear fits the science or the size of the government stockpile? To strive your utmost to maintain your humanity even while barricaded behind visors and masks? Rachel is a palliative care doctor who looked after the most gravely unwell patients on the Covid-19 wards of her hospital. Amid the tensions, fatigue and rising death toll, she witnessed the courage of patients and NHS staff alike in conditions of unprecedented adversity. For all the bleakness and fear, she found that moments that could stop you in your tracks abounded. People who rose to their best, upon facing the worst, as a microbe laid waste to the population. Her new book, Breathtaking, is an unflinching insider's account of medicine in the time of coronavirus. Drawing on testimony from nursing, acute and intensive care colleagues - as well as, crucially, her patients - Clarke argue that this age of contagion has inspired a profound attentiveness to - and gratitude for - what matters most in life.

Three times in the last century, influenza viruses have undergone major genetic changes resulting in global pandemics that had devastating effects. The most infamous pandemic was the "Spanish Flu" which affected up to 25% of the world population and is thought to have killed at least 40 million people. In 1997 and 2003, a new influenza A virus of H5N1 subtype emerged in Asia and was transmitted directly from birds to humans with lethal outcomes. Despite monumental efforts to contain them, the H5N1 viruses expanded their territory and caused a major outbreak in wild waterfowl in China in 2005. Despite extensive, coordinated efforts by various agencies and disciplines, both national and international, we are ill-equipped for a new influenza pandemic. In fact, it is highly unlikely that adequate supplies of vaccine for the H5N1 viruses will be prepared prior to the occurrence of the next pandemic. To combat the outbreaks that will undoubtedly occur in the near future, a better understandi

This book discusses normal sex-related differences in lung structure and function and the role these differences play in lung disease. New research on the effects of sex hormone signaling on specific cell types of the lung has begun to reveal how these hormones may drive or prevent lung disease. Expertly written chapters examine the effects of sex hormones on normal pulmonary structure and function, hormone signaling in lung health, and specific diseases such as chronic obstructive pulmonary disease, asthma, pulmonary hypertension, and lung cancer. Gender, Sex Hormones, and Respiratory Disease: A Comprehensive Guide focuses on our current understanding and the gaps in research, with suggestions for future directions and implications for therapy. This book is a useful reference for pulmonologists and researchers and will prompt further inquiry aimed at improving overall lung health.

Respiratory function is a major determinant of the overall quality of health and well-being of an individual. This book runs the gamut of chapters devoted to chronic cough-related conditions in children and adults, health care quality and safety, environmental pollution health effects, efficiency of therapeutic approaches and a mutual dependence of respiratory and non-respiratory illnesses. An integrated approach to the investigation and treatment of sleep disordered breathing as well as the use of new and more efficient diagnostic strategies for pleural tuberculosis are presented. Chapters focus on translating science into practice, with an eye on presymptomatic identification of serious ailments for which there could be more effective therapy, leading to improved general health outcomes. This book includes chapters about disorders which will be of interest to clinicians, family practitioners and medical researchers.

The impairment of lung function caused by environmental exposure to pollutants and toxicants is a rising health problem, particularly in highly industrialized parts of the world. The problem is urgently calling for the development of new methodologies to assess both the level of elemental exposure and the effects for quality of health and longevity. This volume provides state-of-the-art information about the recent advances in occupational and non-occupational pollutant-related disorders of the respiratory tract, and the assessment of a threat they pose for the health-span. Heavy traffic-related air pollution, unnoticeable but salient health detriment, is dealt with at length.

This comprehensive book thoroughly covers the spectrum of rhinitis conditions and related comorbidities. Rhinitis and Related Upper Respiratory Conditions is a unique resource that delivers essential clinical information, addressing the varying patient populations which might be encountered in different types of clinical settings. Chapters range from topics such as pediatric, adult, geriatric, and occupational rhinitis, while also covering the full array of rhinitis subtypes and their complications. Later chapters address secondary causes of rhinitis such as systemic diseases manifesting as rhinitis, drug-induced rhinitis, and CSF leak. Written by experts in the field, every chapter is structured to contain clinical cases which illustrate the typical patient presentation, and their diagnostic work-up and treatment, providing the knowledge needed to further improve diagnosis and care for the patient with rhinitis. Rhinitis and Related Upper Respiratory Conditions is an ideal resource for allergists, primary care physicians, and health care extenders, to help them recognize and further improve care of patients with rhinitis.

Use this all-in-one reference in the lab - and to prepare for PFT credentialing exams! Ruppel's Manual of Pulmonary Function Testing, 12th Edition provides comprehensive coverage of common pulmonary function tests, testing techniques, and the pathophysiology that may be evaluated by each test. It also includes information on equipment, measurement software, reference values, and quality assurance, so you can develop the testing skills you need to find and assess lung abnormalities and conditions such as asthma, COPD, and emphysema. Written by Carl D. Mottram, a well-known expert in pulmonary function procedures, this bestselling guide helps you get accurate test results every time. Entry- and Advanced-Level objectives prepare you for success on the NBRC's Pulmonary Function Technologist credentialing examinations and follow the content guidelines of the CPFT and RPFT exam matrices from the National Board for Respiratory Care. How To boxes provide step-by-step guidelines to performing pulmonary function tests, taking the guesswork out of completing accurate and result-producing tests. Case studies provide problem-solving challenges for real-life patient scenarios, including each case history, PFT testing results, a technologist's comments, and questions and answers. PFT Tips highlight and reinforce the most important pulmonary function testing information in every chapter. Convenient study features include key terms, chapter outlines, learning objectives, chapter summary points, suggested readings, a glossary, and self-assessment questions. Authoritative, all-in-one resource eliminates the need to search for information in other sources. Criteria for acceptability and repeatability are included in each test section, as well as interpretive strategies to help you adhere to recognized testing standards. NEW! Indications for Pulmonary Function Testing chapter Includes updates in alignment with the 2019 ATS-ERS Spirometry Standards. NEW! Spirometry chapter adds updated Information per the new 2019 ATS-ERS Spirometry Technical Standard. NEW! Diffusing Capacity Tests chapter is aligned with the 2014 ERS-ATS Technical Standard and the 2017 Global Lung Initiative (GLI) DLCO reference set. NEW! Bronchoprovocation Challenge Testing chapter is updated with the 2017 ERS Methacholine Challenge Technical Standard and 2018 ERS Indirect Bronchial Challenge Testing (e.g., mannitol, exercise, hyperventilation, cold air). NEW! Specialized Test Regimens chapter includes 2018 ATS Reference Values in Children. NEW! Pulmonary Function Testing Equipment chapter is updated with new equipment and vendors. NEW! Quality Systems in the Pulmonary Function Laboratory chapter is updated with the newest version of the Clinical and Laboratory Standards Institutes (CLSI) Quality Management System (QMS01), which is the basis for any laboratory quality program, and a new table of recommended target CVs for Biological control (BioQC). NEW! Reference Values and Interpretation Strategies chapter adds new GLI (Global Lung Function Initiative) reference sets for Diffusing of the Lung and Lungs Volumes.

This book addresses several burning issues concerning diseases involving the lungs and respiratory tract. It discusses the epidemiology, mechanisms, prevention, and diagnosis of chest conditions such as chronic obstructive pulmonary disease, sleep apnea and respiratory infections. Further, it examines the intertwined connection between oxidative stress, cardiovascular disorders such as hypertension, and the occurrence and course of obstructive sleep apnea. It also provides pulmonologists with valuable information on the diagnosis and treatment of patients with severe airway obstruction or respiratory tract infections. Other topics covered include viral infections of the airways, such as influenza, particularly in high-risk groups like pediatric populations, as well as psychosocial aspects, e.g., quality of life in lung cancer patients. Combining basic science and clinical practice, the articles provide key insights and highlight the areas of still limited understanding of disease processes. Stimulating new directions in clinical practice, this collection of articles is intended for respiratory physicians, clinical experts, family practitioners, and all allied healthcare professionals.

Presenting the basic concepts and clinical implications of respiratory infection, with special emphasis on the role of the immune system, the field's leading researchers contribute detailed chapters on most of the major pathogenic and opportunistic bacteria, fungi, and viruses. Their work will stimulate new research by microbiologists and immunologists, teach clinicians the interaction between microorganisms and the host, and provide health professionals with information necessary to evaluate public health procedures.